FCGBP and Parkinson disease: In summary, we provide evidence for upregulation of FCGBP mRNA levels, not only in patients with PD but also in those with a high risk of PD, suggesting that FCGBP could be important in PD gut-brain interactions, mediating the connection between the microbiota and intestinal inflammatory processes, as well as in neuroinflammation and neurodegeneration.